New Drug for Homozygous Familial Hypercholesterolemia Approved by the FDA

The Food and Drug Administration (FDA) approved today a new drug to treat adult and pediatric patients aged 12 years and older with Homozygous Familial Hypercholesterolemia (HoFH), the rare and [...]